BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25553350)

  • 1. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
    Ji GH; Li M; Cui Y; Wang JF
    Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
    Zhang F; Yang Y; Guo C; Wang Y
    Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
    Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
    Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
    Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
    Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
    de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
    J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
    Li Z; Wang J; Wang F; Ma Z; Yu Z
    Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
    Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
    J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
    Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
    Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.
    Yin M; Yan J; Wei S; Wei Q
    Carcinogenesis; 2010 May; 31(5):850-7. PubMed ID: 20176653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
    Chatterjee K; Williamson AL; Hoffman M; Dandara C
    J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CASP-8 gene polymorphisms and cancer risk in some Asian population based on a HuGE review and meta-analysis.
    Zhang YJ; Zhong XP; Chen Y; Liu SR; Wu G; Liu YF
    Genet Mol Res; 2013 Feb; 12(4):6466-76. PubMed ID: 23479148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
    Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
    Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
    Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
    BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Montalar Salcedo J; Castel Sánchez V; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2010 Jan; 119(1):87-93. PubMed ID: 19214744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
    Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
    Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
    Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
    Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
    Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
    Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.